CSF B - Lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis

Journal of Neurology

Volumn 255, Issue 5, 2008, Pages 732-737

  Ljostad U ^a   Mygland, A ^a,b,c  

^a Sørlandet Sykehus HF Kristiansand ^*  (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF BERGEN   (Norway)

Author keywords

Antibodies; Borrelia burgdorferi; Chemokines; Diagnosis; Lyme neuroborreliosis; Sensitivity; Specificity

Indexed keywords

CXCL13 CHEMOKINE;

ADULT; ARTICLE; BORRELIA BURGDORFERI; CELL COUNT; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HUMAN; LYME DISEASE; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MULTIPLE SCLEROSIS; PRIORITY JOURNAL;

ACUTE DISEASE; ADULT; AGED; ANTIBODIES; B-LYMPHOCYTES; BIOLOGICAL MARKERS; BORRELIA BURGDORFERI; CHEMOKINE CXCL13; COHORT STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LYME NEUROBORRELIOSIS; LYMPHOCYTE ACTIVATION; MALE; MENINGITIS; MIDDLE AGED; MULTIPLE SCLEROSIS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; UP-REGULATION;

EID: 44449150954     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-008-0785-y     Document Type: Article

References (13)

1. (1997) Case definitions for infectious conditions under public health surveillance. Centers for Disease Control and Prevention. MMWR Recomm Rep 46:1-55
2. Stanek G, O'Connell S, Cimmino M, Aberer E, Kristoferitsch W, Granstrom M, Guy E, Gray J (1996) European Union Concerted Action on Risk Assessment in Lyme Borreliosis: clinical case definitions for Lyme borreliosis. Wien Klin Wochenschr 108:741-747
3. (1996) Practice parameter: Diagnosis of patients with nervous system Lyme borreliosis. Report of the Quality Standards Subcommittee of the American Academy of Neurology
4. Hansen K, Lebech AM (1991) Lyme neuroborreliosis: a new sensitive diagnostic assay for intrathecal synthesis of Borrelia burgdorferi - specific immunoglobulin G, A, and M. Ann Neurol 30:197-205
5. Tumani H, Nolker G, Reiber H (1995) Relevance of cerebrospinal fluid variables for early diagnosis of neuroborreliosis. Neurology 45:1663-1670
6. Kaiser R, Rauer S (1998) Analysis of the intrathecal immune response in neuroborreliosis to a sonicate antigen and three recombinant antigens of Borrelia burgdorferi sensu stricto. Eur J Clin Microbiol Infect Dis 17:159-166
7. Ljostad U, Skarpaas T, Mygland A (2007) Clinical usefulness of intrathecal antibody testing in acute Lyme neuroborreliosis. Eur J Neurol 14:873-876
8. Hammers-Berggren S, Hansen K, Lebech AM, Karlsson M (1993) Borrelia burgdorferi-specific intrathecal antibody production in neuroborreliosis: a follow-up study. Neurology 43:169-175
9. Cepok S, Zhou D, Vogel F, Rosche B, Grummel V, Sommer N, Hemmer B (2003) The immune response at onset and during recovery from Borrelia burgdorferi meningoradiculitis. Arch Neurol 60:849-855
10. Rupprecht TA, Pfister HW, Angele B, Kastenbauer S, Wilske B, Koedel U (2005) The chemokine CXCL13 (BLC): a putative diagnostic marker for neuroborreliosis. Neurology 65:448-450
11. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Lijmer JG, Moher D, Rennie D, de Vet HC (2003) Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ 326:41-44
12. Rupprecht TA, Kirschning CJ, Popp B, Kastenbauer S, Fingerle V, Pfister HW, Koedel U (2007) Borrelia garinii induces CXCL13 production in human monocytes through TLR2. Infect Immun 75(9):4351-4356
13. Kaiser R (1995) Intrathecal immune response in neuroborreliosis: importance of cross-reactive antibodies. Zentralbl Bakteriol 282:303-314